ranibizumab
ItalyDrugs containing this active substance
-
It is used in adults to treat various eye diseases that cause vision loss, such as age-related macular degeneration (AMD), proliferative diabetic retinopathy (PDR), diabetic macular edema (DME), and retinal vein occlusion (RVO).
Form: solution for injection
Active substance Dosage ranibizumab - ATC: S01LA04
Manufacturer: SAMSUNG BIOEPIS NL B.V.
-
It is used in adults to treat several eye diseases that cause vision loss, such as age-related macular degeneration (AMD), proliferative diabetic retinopathy (PDR), diabetic macular edema (DME), and retinal vein occlusion (RVO). In premature infants, it is used to treat retinopathy of prematurity (ROP).
Form: solution for injection
Active substance Dosage ranibizumab - ATC: S01LA04
Manufacturer: NOVARTIS EUROPHARM LIMITED
-
It is used in adults to treat various eye diseases that cause vision loss, such as age-related macular degeneration (AMD), proliferative diabetic retinopathy, diabetic macular edema, or retinal vein occlusion.
Form: solution for injection
Active substance Dosage ranibizumab - ATC: S01LA04
Manufacturer: MIDAS PHARMA GMBH
-
It is used in adults to treat various eye diseases that cause vision loss, such as age-related macular degeneration (AMD), proliferative diabetic retinopathy (PDR), diabetic macular edema (DME), and retinal vein occlusion (RVO).
Form: solution for injection
Active substance Dosage ranibizumab - ATC: S01LA04
Manufacturer: MIDAS PHARMA GMBH
-
It is used in adults to treat various eye diseases that cause vision loss, such as age-related macular degeneration (AMD), proliferative diabetic retinopathy (PDR), diabetic macular edema (DME), and retinal vein occlusion (RVO).
Form: solution for injection
Active substance Dosage ranibizumab - ATC: S01LA04
Manufacturer: STADA ARZNEIMITTEL AG